Hangzhou AGS MedTech Co. Ltd.
SSSE:68858153.24
CNY
+0.87
(+1.66%)
ISIN
CNE100005ZF0
Return %
Stock
S&P 500
1Y
-19.24
14.20
3Y
-33.45
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Cheng Zhang
- Full Time Employees
- 807
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Hangzhou China
- IPO Date
- May 19, 2023
- Website
- bioags.com
- Similar Companies
- Business
- Hangzhou AGS MedTech Co., Ltd. is a China-based medical device company engaged in the research, development, manufacturing, and commercialization of minimally invasive endoscopic diagnostic and therapeutic devices and supporting electrosurgical equipment. Founded in 2010 and headquartered in Hangzhou, Zhejiang Province, China, the company operates across the medical instruments and supplies industry, serving hospitals, outpatient surgical centers, and healthcare providers worldwide specializing in gastroenterology, hepatobiliary endoscopy, and digestive disease interventions. The company’s core product portfolio is categorized into several primary segments: hemostasis and closure devices, including disposable endoscopic hemostatic clips, clips-on-demand systems, and tissue traction clips; Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD) instruments, including electrosurgical knives, polypectomy snares, disposable sclerotherapy injection needles, and bipolar coagulation forceps; Endoscopic Retrograde Cholangiopancreatography (ERCP) and biliary-pancreatic therapeutic instruments, including sphincterotomes, disposable stone extraction baskets, stone retrieval balloons, and endoscopic guidewires; diagnostic biopsy devices, including standard disposable biopsy forceps, swinging biopsy forceps, and cytology brushes; electrosurgical and surgical auxiliary equipment, including high-frequency electrosurgical generators, bipolar electrosurgical units, endoscopic carbon dioxide regulation units, and endoscopic water irrigation pumps; and general endoscopic accessories, including disposable endoscope cleaning brushes, retrieval nets, and bite blocks. Hangzhou AGS MedTech distributes its products domestically across China and exports to more than 40 countries and regions globally, including Germany, the United Kingdom, Italy, the United States, Japan, South Korea, Thailand, Singapore, and Australia, utilizing both direct sales models and original design manufacturer (ODM) partnerships. The company manages international operations through subsidiaries including AGS MedTech B.V. in the Netherlands, AGS MedTech Co., Ltd. in the United States, AGS MedTech (Thailand) Co., Ltd., AGS MedTech Singapore Pte. Ltd., and AGS MedTech HK Limited. In recent developments, the company completed its initial public offering on the Shanghai Stock Exchange Science and Technology Innovation Board under the ticker symbol 688581. To support accelerating market demand and long-term production needs, the company initiated the construction and operational expansion of a new modern manufacturing facility in Hangzhou. Hangzhou AGS MedTech has also secured winning bid allocations in China's national and provincial centralized volume-based procurement programs for its primary gastrointestinal consumables, expanded its global regulatory footprint through new U.S. FDA 510(k) clearances and European Union Medical Device Regulation (EU MDR) conformity certifications, and broadened its clinical portfolio with next-generation bipolar electrosurgical cutting systems and specialized early-stage gastrointestinal tumor intervention solutions.